GRAIL CEO Buys Shares Ahead of FDA Decision on Galleri, Boosting Insider Confidence
GRAIL insider buying signals confidence as the FDA panel eyes a favorable Galleri review, hinting at potential share price upside amid regulatory milestones.
3 minutes to read